Skimmianine as a novel therapeutic agent suppresses proliferation and migration of human esophageal squamous cell carcinoma via blocking the activation of ERK1/2 / Yang Liu ... [et al.]. Neoplasma Vol. 69, no. 3 (2022), s. 571-582